Japan
· Delayed Price · Currency is JPY Cyfuse Biomedical K.K. Statistics
Total Valuation
TYO:4892 has a market cap or net worth of JPY 7.67 billion. The enterprise value is 5.67 billion.
| Market Cap | 7.67B |
| Enterprise Value | 5.67B |
Important Dates
The last earnings date was Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:4892 has 8.30 million shares outstanding. The number of shares has increased by 3.62% in one year.
| Current Share Class | 8.30M |
| Shares Outstanding | 8.30M |
| Shares Change (YoY) | +3.62% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 13.43% |
| Owned by Institutions (%) | -1.01% |
| Float | 4.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 112.85 |
| PB Ratio | 3.21 |
| P/TBV Ratio | 3.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.00 |
| EV / Sales | 83.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.75, with a Debt / Equity ratio of 0.34.
| Current Ratio | 4.75 |
| Quick Ratio | 4.58 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -82.36 |
Financial Efficiency
Return on equity (ROE) is -30.06% and return on invested capital (ROIC) is -16.14%.
| Return on Equity (ROE) | -30.06% |
| Return on Assets (ROA) | -15.59% |
| Return on Invested Capital (ROIC) | -16.14% |
| Return on Capital Employed (ROCE) | -33.35% |
| Revenue Per Employee | 3.24M |
| Profits Per Employee | -38.57M |
| Employee Count | 21 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.82 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.89% in the last 52 weeks. The beta is 1.69, so TYO:4892's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | +25.89% |
| 50-Day Moving Average | 995.70 |
| 200-Day Moving Average | 700.20 |
| Relative Strength Index (RSI) | 42.77 |
| Average Volume (20 Days) | 125,090 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TYO:4892 had revenue of JPY 68.00 million and -810.00 million in losses. Loss per share was -99.72.
| Revenue | 68.00M |
| Gross Profit | 24.00M |
| Operating Income | -906.00M |
| Pretax Income | -808.00M |
| Net Income | -810.00M |
| EBITDA | -868.50M |
| EBIT | -906.00M |
| Loss Per Share | -99.72 |
Balance Sheet
The company has 2.83 billion in cash and 820.00 million in debt, giving a net cash position of 2.01 billion or 241.43 per share.
| Cash & Cash Equivalents | 2.83B |
| Total Debt | 820.00M |
| Net Cash | 2.01B |
| Net Cash Per Share | 241.43 |
| Equity (Book Value) | 2.39B |
| Book Value Per Share | 292.32 |
| Working Capital | 2.41B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 35.29% |
| Operating Margin | -1,332.35% |
| Pretax Margin | -1,188.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TYO:4892 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.62% |
| Shareholder Yield | -3.62% |
| Earnings Yield | -10.56% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TYO:4892 has an Altman Z-Score of 2.1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.1 |
| Piotroski F-Score | n/a |